Plasmodium falciparum: new molecular targets with potential for antimalarial drug development
Published 2009 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Plasmodium falciparum: new molecular targets with potential for antimalarial drug development
Authors
Keywords
-
Journal
Expert Review of Anti-Infective Therapy
Volume 7, Issue 9, Pages 1087-1098
Publisher
Informa UK Limited
Online
2009-11-03
DOI
10.1586/eri.09.93
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The M17 Leucine Aminopeptidase of the Malaria ParasitePlasmodium falciparum: Importance of Active Site Metal Ions in the Binding of Substrates and Inhibitors
- (2009) Selma Maric et al. BIOCHEMISTRY
- Fumagillin and Fumarranol Interact with P. falciparum Methionine Aminopeptidase 2 and Inhibit Malaria Parasite Growth In Vitro and In Vivo
- (2009) Xiaochun Chen et al. CHEMISTRY & BIOLOGY
- Homology modeling in drug discovery: current trends and applications
- (2009) Claudio N. Cavasotto et al. DRUG DISCOVERY TODAY
- Inhibition of Hypoxanthine-Guanine Phosphoribosyltransferase by Acyclic Nucleoside Phosphonates: A New Class of Antimalarial Therapeutics
- (2009) Dianne T. Keough et al. JOURNAL OF MEDICINAL CHEMISTRY
- Failure of artesunate-mefloquine combination therapy for uncomplicated Plasmodium falciparum malaria in southern Cambodia
- (2009) William O Rogers et al. MALARIA JOURNAL
- Structural basis for the inhibition of the essentialPlasmodium falciparumM1 neutral aminopeptidase
- (2009) Sheena McGowan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Antimalarial Activity of Phenylthiazolyl-Bearing Hydroxamate-Based Histone Deacetylase Inhibitors
- (2008) G. S. Dow et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Potent Antimalarial Activity of Histone Deacetylase Inhibitor Analogues
- (2008) K. T. Andrews et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Stronger Activity of Human Immunodeficiency Virus Type 1 Protease Inhibitors against Clinical Isolates of Plasmodium vivax than against Those of P. falciparum
- (2008) U. Lek-Uthai et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Antimalarial Drugs – What is in Use and What is in the Pipeline
- (2008) Martin Schlitzer ARCHIV DER PHARMAZIE
- Structural insights into the Plasmodium falciparum histone deacetylase 1 (PfHDAC-1): A novel target for the development of antimalarial therapy
- (2008) Prasenjit Mukherjee et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Clinical Pharmacology of Artemisinin-Based Combination Therapies
- (2008) Francesca T Aweeka et al. CLINICAL PHARMACOKINETICS
- HIV Protease Inhibitors Inhibit the Development of Preerythrocytic-StagePlasmodiumParasites
- (2008) Charlotte V. Hobbs et al. JOURNAL OF INFECTIOUS DISEASES
- Plasmodium vivax: who cares?
- (2008) Mary R Galinski et al. MALARIA JOURNAL
- A green fluorescent protein-based assay for determining gametocyte production in Plasmodium falciparum
- (2008) M DIXON et al. MOLECULAR AND BIOCHEMICAL PARASITOLOGY
- Predicting functional residues in Plasmodium falciparum plasmepsins by combining sequence and structural analysis with molecular dynamics simulations
- (2008) Pedro A. Valiente et al. PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS
- EPIDEMIOLOGY: Lower Malaria Numbers Reflect Better Estimates and a Glimmer of Hope
- (2008) M. Enserink SCIENCE
- Recent highlights in antimalarial drug resistance and chemotherapy research
- (2008) David A. Fidock et al. TRENDS IN PARASITOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started